Viewing Study NCT03617367


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-24 @ 10:52 AM
Study NCT ID: NCT03617367
Status: COMPLETED
Last Update Posted: 2022-01-28
First Post: 2018-07-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
Sponsor: Revance Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-09-05
Start Date Type: ACTUAL
Primary Completion Date: 2021-05-25
Primary Completion Date Type: ACTUAL
Completion Date: 2021-05-25
Completion Date Type: ACTUAL
First Submit Date: 2018-07-12
First Submit QC Date: None
Study First Post Date: 2018-08-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2022-01-24
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2022-01-25
Last Update Post Date: 2022-01-28
Last Update Post Date Type: ACTUAL